Your browser is no longer supported. Please, upgrade your browser.
SNY [NASD]
Sanofi
Index- P/E17.72 EPS (ttm)2.71 Insider Own16.40% Shs Outstand2.50B Perf Week0.48%
Market Cap122.80B Forward P/E10.99 EPS next Y4.38 Insider Trans0.00% Shs Float2.26B Perf Month-7.18%
Income6.82B PEG2.36 EPS next Q1.18 Inst Own8.20% Short Float0.25% Perf Quarter-9.58%
Sales44.06B P/S2.79 EPS this Y324.80% Inst Trans2.83% Short Ratio2.73 Perf Half Y-3.04%
Book/sh29.68 P/B1.62 EPS next Y15.21% ROA- Target Price63.40 Perf Year-5.24%
Cash/sh4.47 P/C10.76 EPS next 5Y7.50% ROE- 52W Range44.76 - 54.26 Perf YTD-0.97%
Dividend1.93 P/FCF- EPS past 5Y24.10% ROI14.20% 52W High-11.99% Beta0.56
Dividend %4.01% Quick Ratio1.10 Sales past 5Y1.40% Gross Margin67.60% 52W Low6.68% ATR0.62
Employees99412 Current Ratio1.50 Sales Q/Q1.00% Oper. Margin- RSI (14)32.74 Volatility0.74% 0.86%
OptionableYes Debt/Eq0.34 EPS Q/Q-70.00% Profit Margin- Rel Volume0.63 Prev Close48.12
ShortableYes LT Debt/Eq0.30 EarningsJul 29 BMO Payout- Avg Volume2.04M Price47.75
Recom1.00 SMA20-3.55% SMA50-5.95% SMA200-4.92% Volume584,103 Change-0.76%
Sep-27-21Upgrade SVB Leerink Mkt Perform → Outperform
Jan-15-21Initiated Deutsche Bank Sell
Sep-29-20Initiated Berenberg Hold
Mar-17-20Upgrade Barclays Underweight → Equal Weight
Mar-11-20Upgrade Goldman Neutral → Buy
Feb-11-20Initiated SVB Leerink Mkt Perform
Jan-06-20Upgrade JP Morgan Neutral → Overweight
Sep-23-19Upgrade Guggenheim Neutral → Buy
Sep-20-19Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-03-19Initiated Bernstein Outperform
Aug-14-19Upgrade UBS Neutral → Buy
Dec-11-18Upgrade Jefferies Hold → Buy
Nov-01-18Upgrade Barclays Underweight → Equal Weight
Oct-09-18Initiated Guggenheim Neutral
Sep-10-18Upgrade BofA/Merrill Neutral → Buy
Aug-10-18Upgrade Citigroup Neutral → Buy
Mar-23-18Upgrade Liberum Hold → Buy
Jan-23-18Downgrade Barclays Equal Weight → Underweight
Dec-06-17Downgrade BofA/Merrill Buy → Neutral
Dec-01-17Downgrade Morgan Stanley Overweight → Underweight
Sep-28-21 11:03AM  
08:59AM  
07:58AM  
06:01AM  
05:55AM  
05:10AM  
02:22AM  
02:00AM  
Sep-27-21 02:36PM  
Sep-24-21 02:02PM  
01:30AM  
Sep-22-21 01:43PM  
Sep-21-21 07:46PM  
01:00AM  
Sep-20-21 01:42PM  
09:09AM  
06:45AM  
Sep-19-21 11:30AM  
Sep-18-21 07:03AM  
05:57AM  
Sep-17-21 03:59PM  
03:56PM  
02:09PM  
07:58AM  
04:30AM  
Sep-15-21 01:51PM  
Sep-14-21 09:26AM  
Sep-13-21 01:40PM  
Sep-11-21 06:12AM  
Sep-10-21 05:17PM  
08:12AM  
Sep-09-21 02:40PM  
02:24PM  
11:52AM  
10:47AM  
10:04AM  
06:31AM  
01:00AM  
Sep-08-21 04:11PM  
02:31PM  
01:37PM  
01:20PM  
10:47AM  
09:48AM  
08:38AM  
08:08AM  
06:36AM  
06:30AM  
03:14AM  
01:40AM  
01:15AM  
01:00AM  
Sep-07-21 10:02PM  
04:05PM  
02:12PM  
Sep-03-21 01:58PM  
10:06AM  
Sep-02-21 02:18PM  
Sep-01-21 02:14PM  
10:44AM  
Aug-31-21 01:25PM  
07:12AM  
Aug-30-21 02:06PM  
10:59AM  
10:51AM  
06:58AM  
01:00AM  
Aug-27-21 02:07PM  
Aug-25-21 01:38PM  
12:31PM  
10:14AM  
Aug-24-21 02:16PM  
Aug-23-21 01:57PM  
Aug-20-21 02:54PM  
02:34PM  
01:23PM  
Aug-19-21 03:01PM  
Aug-18-21 02:06PM  
Aug-16-21 04:19PM  
01:50PM  
Aug-13-21 02:05PM  
09:54AM  
Aug-12-21 02:11PM  
11:05AM  
Aug-11-21 02:20PM  
Aug-09-21 02:16PM  
12:43PM  
Aug-06-21 11:42AM  
11:07AM  
09:30AM  
Aug-05-21 01:47PM  
10:09AM  
06:00AM  
02:06AM  
Aug-04-21 02:30PM  
08:21AM  
Aug-03-21 09:05PM  
05:00PM  
04:32PM  
04:30PM  
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. It also has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration with TrialSpark Inc. to execute clinical research studies in the areas of chronic obstructive pulmonary disease. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanofi10% OwnerAug 02Buy15.0066,6671,000,0053,155,169Aug 02 08:34 PM